Income Statement Cochlear Limited
Equities
COH
AU000000COH5
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.89 AUD | +2.24% |
|
-3.17% | -62.83% |
| 14/05 | From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis | RE |
| 04/05 | From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis | RE |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 149.76Cr | 164.83Cr | 193.61Cr | 223.56Cr | 234.31Cr | |||||
Total Revenues | 149.76Cr | 164.83Cr | 193.61Cr | 223.56Cr | 234.31Cr | |||||
Cost of Goods Sold, Total | 41Cr | 41Cr | 49Cr | 56Cr | 62Cr | |||||
Gross Profit | 108.74Cr | 123.73Cr | 144.81Cr | 167.35Cr | 172.79Cr | |||||
Selling General & Admin Expenses, Total | 56Cr | 66Cr | 81Cr | 90Cr | 94Cr | |||||
R&D Expenses | 20Cr | 21Cr | 24Cr | 28Cr | 29Cr | |||||
Other Operating Expenses | -83L | -1.2Cr | -1.35Cr | -1.07Cr | -2.64Cr | |||||
Other Operating Expenses, Total | 74Cr | 86Cr | 104.18Cr | 116.39Cr | 120.5Cr | |||||
Operating Income | 34Cr | 38Cr | 41Cr | 51Cr | 52Cr | |||||
Interest Expense, Total | -1.2Cr | -86L | -94L | -92L | -1.1Cr | |||||
Interest And Investment Income | 36L | 24L | 1.65Cr | 1.9Cr | 1.17Cr | |||||
Net Interest Expenses | -84L | -62L | 71L | 98L | 7L | |||||
Income (Loss) On Equity Invest. | -17L | - | -2L | -6L | -9L | |||||
Currency Exchange Gains (Loss) | -1.58Cr | 1L | -1.02Cr | -48L | -16L | |||||
EBT, Excl. Unusual Items | 32Cr | 37Cr | 40Cr | 51Cr | 52Cr | |||||
Merger & Related Restructuring Charges | - | - | - | -2.82Cr | - | |||||
Gain (Loss) On Sale Of Investments | 5.2Cr | 1.73Cr | -64L | -13L | -26L | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | -64L | - | - | - | - | |||||
Other Unusual Items | 16L | 17L | - | 3L | - | |||||
EBT, Incl. Unusual Items | 37Cr | 39Cr | 40Cr | 48Cr | 52Cr | |||||
Income Tax Expense | 3.92Cr | 10Cr | 9.6Cr | 13Cr | 13Cr | |||||
Earnings From Continuing Operations | 33Cr | 29Cr | 30Cr | 36Cr | 39Cr | |||||
Net Income to Company | 33Cr | 29Cr | 30Cr | 36Cr | 39Cr | |||||
Net Income - (IS) | 33Cr | 29Cr | 30Cr | 36Cr | 39Cr | |||||
Net Income to Common Incl Extra Items | 33Cr | 29Cr | 30Cr | 36Cr | 39Cr | |||||
Net Income to Common Excl. Extra Items | 33Cr | 29Cr | 30Cr | 36Cr | 39Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.97 | 4.4 | 4.57 | 5.44 | 5.94 | |||||
Basic EPS - Continuing Operations | 4.97 | 4.4 | 4.57 | 5.44 | 5.94 | |||||
Basic Weighted Average Shares Outstanding | 6.57Cr | 6.58Cr | 6.58Cr | 6.55Cr | 6.54Cr | |||||
Net EPS - Diluted | 4.97 | 4.4 | 4.56 | 5.43 | 5.93 | |||||
Diluted EPS - Continuing Operations | 4.97 | 4.4 | 4.56 | 5.43 | 5.93 | |||||
Diluted Weighted Average Shares Outstanding | 6.57Cr | 6.58Cr | 6.59Cr | 6.57Cr | 6.56Cr | |||||
Normalized Basic EPS | 3.03 | 3.56 | 3.83 | 4.9 | 4.98 | |||||
Normalized Diluted EPS | 3.03 | 3.56 | 3.82 | 4.89 | 4.96 | |||||
Dividend Per Share | 2.55 | 3 | 3.3 | 4.1 | 4.3 | |||||
Payout Ratio | 23.15 | 67.1 | 65.67 | 68.86 | 71.54 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 39Cr | 42Cr | 45Cr | 55Cr | 57Cr | |||||
EBITA | 36Cr | 39Cr | 42Cr | 52Cr | 53Cr | |||||
EBIT | 34Cr | 38Cr | 41Cr | 51Cr | 52Cr | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 10.72 | 26.59 | 24.21 | 26.4 | 25 | |||||
Total Current Taxes | 2.33Cr | 5.71Cr | 11Cr | 14Cr | 17Cr | |||||
Total Deferred Taxes | 1.59Cr | 4.76Cr | -1.26Cr | -1.44Cr | -4.49Cr | |||||
Normalized Net Income | 20Cr | 23Cr | 25Cr | 32Cr | 33Cr | |||||
Interest on Long-Term Debt | 66L | 66L | 67L | 72L | 85L | |||||
Non-Cash Pension Expense | 14L | 15L | 19L | 20L | 21L | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 11Cr | 16Cr | 20Cr | 21Cr | 21Cr | |||||
Research And Development Expense From Footnotes | 20Cr | 21Cr | 24Cr | 28Cr | 29Cr | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 81L | 1.08Cr | 1.59Cr | 1.96Cr | 2.21Cr | |||||
Total Stock-Based Compensation | 81L | 1.08Cr | 1.59Cr | 1.96Cr | 2.21Cr |
- Stock Market
- Equities
- COH Stock
- Financials Cochlear Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















